Market intelligence for competitive advantage to the world's leading and emerging medtech companies.

Reports | Medtech Startups | Fundings

Emerging Global Market for Neurointerventional Technologies in Stroke, 2014-2019

· Report #C310 · 194 Pages · 34 Exhibits
Published September 2015
*** Excerpts available upon request ***

Price: $2,250 (print or PDF; add $200 for both).
Site/Global License also available.

Order online or fax/email us your order form.

This report is a detailed market and technology assessment and forecast of the products and technologies in the management of acute stroke. The report describes the epidemiology, etiology and management of hemorrhagic stroke, ischemic stroke, subarachnoid hemorrhage, and transient ischemic attack, characterizing the patient populations, their current clinical management, and trends in clinical management as new techniques and technologies are expected to be developed and emerge. The report details the currently available products and technologies, and the manufacturers offering them. The report details the products and technologies under development and markets for each in the treatment of acute stroke. The report provides a current and forecast to 2019 by region /country for the U.S., Western Europe, the major Asia-Pacific states (China, India, and Japan), and the rest of world. The report profiles the most top companies in this industry, providing status and forecast data on their current products, current market position, and products under development.

Table of Contents

Executive Summary
Cerebral Aneurysm and AVM Embolization Systems
Carotid Artery Stenting Systems
Left Atrial Appendage Closure Systems
Cerebral Thrombectomy Systems

Section 1:    Global Healthcare Market Environment
1.1    United States
1.2    Major Western European States
1.2.1    Overview of European Healthcare: Spending, Facilities/Manpower, Reimbursement, EU Impact
1.2.2    National Healthcare Profiles: France, Germany, Spain, United Kingdom
1.3    Major Asian States: China, India, Japan

Section 2:    CLINICAL PRACTICE, Etiology and Epidemiology of Acute Stroke
2.1    Etiology of Stroke
2.1.1    Hemorrhagic Stroke
2.1.1.1    Intracerebral Hemorrhage
2.1.1.2    Causes, Risk Factors and Common Symptoms
2.1.1.3    Management of Acute ICH
2.1.2    Subarachnoid Hemorrhage
2.1.2.1    Causes, Risk Factors and Common Symptoms of SAH
2.1.2.2    Diagnostic and Therapeutic Management of SAH
2.1.3    Ischemic Stroke
2.1.3.1    Thrombotic Stroke - Causes & Mechanisms
2.1.3.2    Embolic Stroke - Causes & Mechanisms
2.1.3.3    Hypoperfusion Stroke – Causes & Mechanisms
2.1.3.4    Symptoms and Risk Factors for Ischemic Stroke
2.1.3.5    Management of Acute Ischemic Stroke
2.1.3.5.1    Ischemic Stroke Diagnostics
2.1.3.5.2    Therapeutic Management of Cerebral Ischemia
2.1.4    Transient Ischemic Attack


Section 3:   PRODUCTS, TECHNOLOGIES, AND TECHNIQUES IN THE Endovascular MANAGEMENT OF Acute Stroke
3.1    Prophylaxis of Hemorrhagic Stroke
3.1.1    Treatment of Cerebral Aneurysms and AVMs
3.1.1.1    Surgical Repair of Cerebral Aneurysms and AVMs
3.1.1.2    Endovascular Embolization of Cerebral Aneurysms and AVMs
3.1.1.2.1    Microcoil Systems
3.1.1.2.2    Liquid Embolic Systems
3.1.1.2.3    Embolization Assisting Stenting Systems
3.1.1.2.4    Flow Diverting Embolization Systems
3.1.1.2.5    Cerebral Aneurysm & AVM Embolization Procedure Volumes
3.2    Prophylaxis and Treatment of Ischemic Stroke
3.2.1    Treatment of Advanced Carotid Artery Stenosis
3.2.1.1    Carotid Endarterectomy

3.2.1.1.1    Carotid Artery Stenting
3.2.1.1.2    CREST Trial Results
3.2.1.1.3    Carotid Stenting Procedure Volumes
3.2.2    Left Atrial Appendage Closure Systems
3.2.2.1    Surgical Closure of Left Atrial Appendage
3.2.2.2    Endovascular Closure of Left Atrial Appendage
3.2.2.2.1    Accumulated Clinical Experience with Endovascular LAA Closure Systems
3.2.2.2.2    Left Atrial Appendage Endovascular Closure Procedure Volumes
3.2.3    Cerebral Thrombectomy Systems
3.2.3.1    Accumulated Clinical Experience with Cerebral Thrombectomy Systems
3.2.3.2    Cerebral Thrombectomy Procedure Volumes
3.2.3.2.1    Intracranial Stenting Systems
3.2.4    Accumulated Clinical Experience with Intracranial Stents

Section 4:    GLOBAL EMERGING Market for endovascular Device-Based Acute Stroke Therapeutic Management
4.1    Cerebral Aneurysm and AVM Embolization Systems
4.1.1    Industry Product Offering
4.1.1.1    Embolics and Associated Delivery Devices
4.1.1.2    Coil Containing Stents
4.1.1.3    Flow Diversion Systems
4.1.2    Market Forecast
4.1.2.1    Competitive Analysis
4.2    Carotid Stenting Systems
4.2.1    Industry Product Offering
4.2.1.1    Emerging Carotid Artery Stenting Technologies
4.2.1.1.1    Flow Reversal Neuroprotection Systems
4.2.1.1.2    Covered Carotid Stenting Systems
4.2.2    Market Forecast
4.2.2.1    Competitive Analysis
4.3    Left Atrial Appendage Closure Systems
4.3.1    Left Atrial Appendage Closure Systems on the Market
4.3.2    Worldwide Market for Endovascular Left Atrial Appendage Closure Systems
4.3.2.1    Suppliers Market Shares
4.4    Cerebral Thrombectomy Systems for Acute Ischemic Stroke Management
4.4.1    Cerebral Thrombectomy Systems on the Market
4.4.2    Cerebral Thrombectomy Product Market
4.4.2.1    Competitive Analysis

Section 5:    Company Profiles
5.1    Abbott Laboratories / Abbott Vascular

5.2    Bard C.R. / Bard Peripheral Vascular

5.3    Boston Scientific

5.4    Codman/DePuy Synthes, Cordis (Johnson & Johnson)

5.5    Cook Medical

5.6    Covidien (Medtronic)

5.7    Medtronic

5.8    MicroVention (Terumo)

5.9    Penumbra, Inc.

5.10    Stryker Corporation (covered in MD&D)

5.11    St. Jude Medical


APPENDIX: COMPANY LISTING

List of Exhibits
Exhibit ES-1: Projected Dynamics of Endovascular Acute Stroke Management Procedures, 2013-2019 (#000)
Exhibit ES-2 Projected Dynamics of Endovascular Acute Stroke Management Product Market, 2013-2019 ($ mil)
Exhibit ES-3: Projected Dynamics of the Global Cerebral Endovascular Embolization Product Market, 2013-2019
Exhibit ES-4: Projected Dynamics of Distally Protected Carotid Artery Stenting Market, 2014-2019
Exhibit ES-5: Projected Dynamics of the Global Left Atrial Appendage Endovascular Closure Product Market, 2013-2019
Exhibit ES-6: Projected Dynamics of the Global Cerebral Thrombectomy Product Market, 2013-2019

Exhibit 1-1: United States, Selected Healthcare/Public Health Indicators, 2014
Exhibit 1-2:  France, Selected Healthcare/Public Health Indicators, 2014
Exhibit 1-3:  Germany, Selected Healthcare/Public Health Indicators, 2014
Exhibit 1-4:  Italy, Selected Healthcare/Public Health Indicators, 2014
Exhibit 1-5:  Spain, Selected Healthcare/Public Health Indicators, 2014
Exhibit 1-6:  United Kingdom, Selected Healthcare/Public Health Indicators, 2014
Exhibit 1-7: China, Selected Healthcare/Public Health Indicators, 2014
Exhibit 1-8: India, Selected Healthcare/Public Health Indicators, 2014
Exhibit 1-9: Japan, Selected Healthcare/Public Health Indicators, 2014

Exhibit 2-1: Clinical Features and Characteristics of Hemorrhagic Stroke
Exhibit 2-2: Clinical Features and Characteristics of Ischemic Stroke

Exhibit 3-1: Findings from Clinical Trials with the Use of Flow Diversion Devices in Treatment of Large, Giant, and Wide Neck Intracranial Aneurysms
Exhibit 3-2: Projected Dynamics of Cerebral Endovascular Embolization Procedures 2013-2019 (#000)
Exhibit 3-3: Projected Dynamics of Protected Carotid Stenting Procedures, 2013-2019 (#000)
Exhibit 3-4: Long-Term Clinical Outcomes of Surgical Left Atrial Appendage (LAA) Closure
Exhibit 3-5: Findings from Selected Clinical Trials with Endovascular LAA Closure Systems
Exhibit 3-6: Projected Dynamics of Left Atrial Appendage Closure Procedures, 2013-2019 (#000)
Exhibit 3-7: Findings from Major Clinical Trials with Cerebral Thrombectomy Systems
Exhibit 3-7: Projected Dynamics of Cerebral Thrombectomy Procedures, 2013-2019 (#000)

Exhibit 4-1: Projected Dynamics of Endovascular Acute Stroke Management Procedures, 2013-2019 (#000)
Exhibit 4-2: Projected Dynamics of Endovascular Acute Stroke Management Product Market, 2013-2019 ($ mil)
Exhibit 4-3: Selected Industry Product Offering in Cerebral Aneurysm & AVM Embolics and Associated Delivery Devices
Exhibit 4-4: Selected Industry Product Offering in Coil Containing Stenting Devices
Exhibit 4-5: Selected Industry Product Offering in Flow Diversion Devices
Exhibit 4-6: Projected Dynamics of Global Intracranial Aneurysm and AVM Endovascular Embolization Product Market, 2013-2019
Exhibit 4-7: Estimated Global Market Shares of the Leading Suppliers of Neurovascular Embolization Systems, 2014
Exhibit 4-8: Selected Industry Product Offering in Carotid Artery Stenting and Distal Protection Systems
Exhibit 4-9: Projected Dynamics of Distally Protected Carotid Artery Stenting Market, 2014-2019
Exhibit 4-10: Estimated 2014 Global Market Shares of the Leading Suppliers of Distally Protected Carotid Artery Stenting Systems
Exhibit 4-11:  Selected Industry Product Offering in Endovascular LAA Closure Systems
Exhibit 4-12 Projected Dynamics of Left Atrial Appendage Closure Procedures/Product Sales, 2013-2019 (#000/$mil)
Exhibit 4-13: Estimated 2014 Global Market Shares of the Leading Suppliers of LAA Closure Systems
Exhibit 4-14: Selected Cerebral Thrombectomy Systems on the U.S. and International Markets
Exhibit 4-15: Projected Dynamics of Cerebral Thrombectomy Product Market, 2013-2019

 


Methodology.
MedMarket Diligence Reports are produced through primary and secondary research. Data is gathered from published sources on products and technologies on the market and under development.  Clinicians and industry representatives are interviewed for their knowledge and insights on product development, market development, clinical practice and trends associated with the evolving use of technologies. Secondary data is used to corroborate and support assessments and projections.  Reports are written and researched by proven authors who are neutral industry insiders, whose familiarity with clinical practice, biomedical techcnologies, companies, and industry dynamics facilitate the research process and ensure high quality and thorough reports.


 

Report #C310

Emerging Global Market for Neurointerventional Technologies in Stroke, 2014-2019 Published September 2015.
   · 194 pages   · 34 Exhibits

 

Price: $2,250 for print or PDF; add $200 to receive for both

Order online or fax/email us your order form.  Site/Global License also available.


Order Reports online for instant download.
See Online Store or any "order online" link.
Credit Card Processing

Reports library access is also available through annual contract.


Medtech Startups Database

MedMarket Diligence offers the Medtech Startups Database.
A unique source of detail on new medical technology companies

About the Medtech Startups Database.